摘要
AIM:To assess the prognostic value of preoperative 18 fluorodeoxyglucose positron emission tomography(FDG-PET)/computed tomography(CT) in patients with resectable colorectal cancer.METHODS:One hundred sixty-three patients with resectable colorectal cancer who underwent FDG-PET/CT before surgery were included.Patient data including pathologic stage at presentation,histology,treatment,disease-free survival and the maximum standardized uptake value(SUVmax) of the primary tumor on FDG-PET/CT were retrospectively analyzed.Median follow up duration was 756(range,419-1355).The primary end point was disease-free survival.RESULTS:Twenty-five of 163 patients(15.3%) had recurrences.The median SUVmax values of the recurrence and no-recurrence groups were 8.9(range,5-24) and 8.2(range,0-23,P = 0.998).Receiver operating characteristic(ROC) curve analysis showed no significant association between SUVmax and recurrence(area under the curve = 0.5,P = 0.998,95% CI:0.389-0.611).Because a statistically significant value was not found,SUVmax was dichotomized at its median of 8.6.The disease-free survival curve was analyzed using the median SUVmax(8.6) as the cut off.Univariate and multivariate analysis did not provide evidence that disease-free survival rates for the subgroups defined by the median SUVmax were significantly different(P = 0.52,P = 0.25).CONCLUSION:Our study suggests that the high FDG uptake of primary mass in resectable colorectal cancer doesn't have a significant relationship with tumor recurrence and disease-free survival.
AIM： To assess the prognostic value of preoperative 18 fluorodeoxyglucose positron emission tomography （FDG-PET）/computed tomography （CT） in patients with resectable colorectal cancer. METHODS： One hundred sixty-three patients with re- sectable colorectal cancer who underwent FDG-PET/CT before surgery were included. Patient data including pathologic stage at presentation, histology, treatment, disease-free survival and the maximum standardized uptake value （SUVmax） of the primary tumor on FDG-PET/CT were retrospectively analyzed. Median follow up duration was 756 （range, 419-1355）. The primary end point was disease-free survival. RESULTS： Twenty-five of 163 patients （15.3%） had recurrences. The median SUVmax values of the re- currence and no-recurrence groups were 8.9 （range, 5-24） and 8.2 （range, 0-23, P = 0.998）. Receiver op- erating characteristic （ROC） curve analysis showed no significant association between SUVmax and recur- rence （area under the curve = 0.5, P = 0.998, 95% CI： 0.389-0.611）. Because a statistically significant value was not found, SUVmax was dichotomized at its median of 8.6. The disease-free survival curve was analyzed using the median SUVmax （8.6） as the cut off. Univariate and multivariate analysis did not provide evidence that disease-free survival rates for the sub- groups defined by the median SUVmax were signifi- cantly different （P = 0.52, P = 0.25）. CONCLUSION： Our study suggests that the high FDG uptake of primary mass in resectable colorectal cancer doesn＇t have a significant relationship with tumor re- currence and disease-free survival.
